Trial ID
USOR 21400
Sponsor ID
TJ004309STM103
A Phase 2 Clinical Study of TJ004309 in Combination with Atezolizumab in Patients with Advanced or Mets Ovarian Cancer and Selected Advanced Solid Tumors.
Principal Investigator
Alexander I. Spira, MD, PhD, FACPLocations
Fairfax Office
Gainesville Office
Loudoun Office
Alexandria Office
Learn More About This Trial
Other Relevant Trials
Trial ID
516-014
Sponsor ID
Mirati
A Multicenter, Open-Label, Extension Study of the Safety and Tolerability of Sitravatinib Alone or in Combination with Other Anticancer Therapies in Patients with Advanced or Metastatic Solid Malignancies
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Trial ID
JBI-802-101
Sponsor ID
Jubilant Therapeutics
A First-in-Human, Open-Label, Dose Escalation and Expansion Study of Orally Administered JBI-802 in Patients with Advanced Solid Tumors
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location